NCT05411107 2024-05-17
Oral Iloprost for the Prevention of Lung Cancer In Former Smokers
National Cancer Institute (NCI)
Phase 2 Withdrawn
Clinical Trials
4 trialsNCT02237183 2023-11-28
Iloprost in Preventing Lung Cancer in Former Smokers
National Cancer Institute (NCI)
Phase 1 Completed
NCT00084409 2020-05-14
Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease
University of Colorado, Denver
Phase 2 Completed
NCT02784899 2018-06-20
Effect of Iloprost on Pulmonary Oxygenation in Patients With Low Diffusing Capacity During One-lung Ventilation
Yonsei University
Phase NA Completed